Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Subject- and Evaluator-blinded, Controlled, Non-inferiority Multicenter, Parallel Group Comparison Study to Evaluate Effectiveness and Safety of Saypha® VOLUME Lidocaine for Midface Augmentation to Correct Volume Deficit

NCT05386030 is registered in ClinicalTrials.gov with Croma-Pharma GmbH as lead sponsor.

NCT NCT05386030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05386030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Subject- and Evaluator-blinded, Controlled, Non-inferiority Multicenter, Parallel Group Comparison Study to Evaluate Effectiveness and Safety of Saypha® VOLUME Lidocaine for Midface Augmentation to Correct Volume Deficit
Lead sponsor
Croma-Pharma GmbH
Phase
Phase 3
Overall status
Completed
Start date
August 16, 2022
Completion date
December 11, 2024
Enrollment
562 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe midface volume deficit